AARTIPHARM Q1 FY27 results at a glance
AARTI PHARMALABS LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹536 cr |
|---|
| Revenue YoY | +38.7% |
|---|
| Operating profit | ₹103 cr |
|---|
| Operating margin | 19.2% |
|---|
| Net profit | ₹76.14 cr |
|---|
| Net profit YoY | +65.4% |
|---|
| Net profit QoQ | +24.6% |
|---|
| Net margin | 14.2% |
|---|
| Basic EPS | ₹8.40 |
|---|
| TTM revenue | ₹1,969 cr |
|---|
| TTM net profit | ₹213 cr |
|---|
| TTM net margin | 10.8% |
|---|
AARTIPHARM Q1 FY27 results: what the numbers say
AARTI PHARMALABS LIMITED (AARTIPHARM) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹536 cr and a net profit of ₹76.14 cr, translating into earnings per share of ₹8.40.
Compared with the same quarter a year earlier, revenue grew strongly by +38.7% and net profit grew sharply by +65.4%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹103 cr, an operating margin of 19.2% versus 18.8% a year ago — a gain of 0.4 percentage points.
AARTIPHARM quarter-wise results table
Net profit
₹76.14 cr
+65.4% YoY
Operating profit
₹103 cr
+41.6% YoY
AARTI PHARMALABS LIMITED (AARTIPHARM) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹536 cr | ₹103 cr | ₹76.14 cr | 19.2% | 14.2% | ₹8.40 | +65.4% | +24.6% |
| Q4 FY262026-03-31 | ₹583 cr | ₹102 cr | ₹61.12 cr | 17.5% | 10.5% | ₹6.74 | — | +27.5% |
| Q3 FY262025-12-31 | ₹432 cr | ₹73.69 cr | ₹47.96 cr | 17.0% | 11.1% | ₹5.29 | — | +71.7% |
| Q2 FY262025-09-30 | ₹418 cr | ₹49.95 cr | ₹27.92 cr | 11.9% | 6.7% | ₹3.08 | — | -39.3% |
| Q1 FY262025-06-30 | ₹386 cr | ₹72.45 cr | ₹46.03 cr | 18.8% | 11.9% | ₹5.08 | — | — |
| TTM (last 4 quarters) | ₹1,969 cr | ₹328 cr | ₹213 cr | 16.7% | 10.8% | ₹23.51 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
AARTIPHARM quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
AARTI PHARMALABS LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹536 cr | ₹583 cr | ₹432 cr | ₹418 cr | ₹386 cr |
|---|
| Total expenses | ₹433 cr | ₹481 cr | ₹359 cr | ₹368 cr | ₹314 cr |
|---|
| Gross profit | ₹299 cr | ₹300 cr | ₹260 cr | ₹209 cr | ₹217 cr |
|---|
| Operating profit (EBIT) | ₹103 cr | ₹102 cr | ₹73.69 cr | ₹49.95 cr | ₹72.45 cr |
|---|
| Operating margin | 19.2% | 17.5% | 17.0% | 11.9% | 18.8% |
|---|
| Interest cost | ₹12.88 cr | ₹16.86 cr | ₹12.58 cr | ₹10.67 cr | ₹6.79 cr |
|---|
| Profit before tax | ₹101 cr | ₹81.68 cr | ₹62.87 cr | ₹38.69 cr | ₹60.82 cr |
|---|
| Tax expense | ₹24.92 cr | ₹20.55 cr | ₹14.91 cr | ₹10.77 cr | ₹14.79 cr |
|---|
| Effective tax rate | 24.7% | 25.2% | 23.7% | 27.8% | 24.3% |
|---|
| Net profit (PAT) | ₹76.14 cr | ₹61.12 cr | ₹47.96 cr | ₹27.92 cr | ₹46.03 cr |
|---|
| Net profit margin | 14.2% | 10.5% | 11.1% | 6.7% | 11.9% |
|---|
| Basic EPS | ₹8.40 | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.08 |
|---|
| Diluted EPS | ₹8.39 | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.08 |
|---|
AARTIPHARM results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +38.7% | — | — | — | — |
|---|
| Revenue QoQ | -8.0% | +34.8% | +3.3% | +8.3% | — |
|---|
| Operating profit YoY | +41.6% | — | — | — | — |
|---|
| Operating profit QoQ | +0.6% | +38.4% | +47.5% | -31.1% | — |
|---|
| Net profit YoY | +65.4% | — | — | — | — |
|---|
| Net profit QoQ | +24.6% | +27.5% | +71.7% | -39.3% | — |
|---|
| EPS YoY | +65.4% | — | — | — | — |
|---|
| EPS QoQ | +24.6% | +27.4% | +71.8% | -39.4% | — |
|---|
AARTIPHARM annual results history
Full-year performance for AARTI PHARMALABS LIMITED, useful for reading each quarter in context.
AARTI PHARMALABS LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,788 cr | ₹2,086 cr | ₹1,816 cr | ₹1,936 cr |
|---|
| Total expenses | ₹1,490 cr | ₹1,709 cr | ₹1,503 cr | ₹1,656 cr |
|---|
| Gross profit | ₹792 cr | ₹868 cr | ₹702 cr | ₹682 cr |
|---|
| Operating profit (EBIT) | ₹298 cr | ₹377 cr | ₹313 cr | ₹280 cr |
|---|
| Operating margin | 16.7% | 18.1% | 17.2% | 14.4% |
|---|
| Interest cost | ₹46.9 cr | ₹26.9 cr | ₹17.21 cr | ₹21.05 cr |
|---|
| Profit before tax | ₹233 cr | ₹361 cr | ₹300 cr | ₹261 cr |
|---|
| Tax expense | ₹58.21 cr | ₹88.28 cr | ₹83.59 cr | ₹67.28 cr |
|---|
| Effective tax rate | 25.0% | 24.5% | 27.8% | 25.8% |
|---|
| Net profit (PAT) | ₹175 cr | ₹272 cr | ₹217 cr | ₹193 cr |
|---|
| Net profit margin | 9.8% | 13.1% | 11.9% | 10.0% |
|---|
| Basic EPS | ₹19.27 | ₹30.06 | ₹23.93 | ₹21.35 |
|---|
| Diluted EPS | ₹19.25 | ₹30.04 | ₹23.93 | ₹21.35 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹536 cr against ₹386 cr in Q1 FY26, and ₹583 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -8.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹433 cr, or 80.8% of revenue, with operating profit grew +41.6% year on year.
Margins, tax and profitability
Net profit of ₹76.14 cr works out to a net margin of 14.2% compared with 11.9% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, AARTI PHARMALABS LIMITED reported profit before tax of ₹101 cr, a tax charge of ₹24.92 cr (effective rate 24.7%), interest cost of ₹12.88 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹61.12 cr in Q4 FY26 to ₹76.14 cr in Q1 FY27, a change of +24.6%.
Trailing twelve months and annual context
Across the trailing four quarters AARTI PHARMALABS LIMITED has generated revenue of ₹1,969 cr and net profit of ₹213 cr, a trailing net margin of 10.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,788 cr with net profit of ₹175 cr and EPS of ₹19.27, versus the prior year where revenue declined -14.3% and profit declined -35.9%.
What to watch in the next AARTIPHARM quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
AARTI PHARMALABS LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
AARTIPHARM results coverage
No results report published for AARTIPHARM yet — our desk covers each quarter within minutes of the filing.
AARTIPHARM quarterly results FAQs
What were AARTI PHARMALABS LIMITED (AARTIPHARM) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), AARTI PHARMALABS LIMITED reported revenue of ₹536 cr and net profit of ₹76.14 cr, a change of +65.4% year on year on +38.7% revenue growth. EPS stood at ₹8.40.
What is AARTIPHARM profit margin in Q1 FY27?
AARTI PHARMALABS LIMITED posted a net profit margin of 14.2% and an operating margin of 19.2% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,969 cr and net profit ₹213 cr.
Did AARTIPHARM results beat the previous quarter?
AARTI PHARMALABS LIMITED net profit changed +24.6% quarter on quarter, from ₹61.12 cr in Q4 FY26 to ₹76.14 cr in Q1 FY27.
When are AARTI PHARMALABS LIMITED (AARTIPHARM) quarterly results?
AARTI PHARMALABS LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see AARTIPHARM latest quarterly results?
Results coverage for AARTIPHARM will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the AARTIPHARM stock page.
What is AARTI PHARMALABS LIMITED annual revenue and profit?
For FY26, AARTI PHARMALABS LIMITED reported full-year revenue of ₹1,788 cr and net profit of ₹175 cr, with EPS of ₹19.27.
How many quarterly results has AARTIPHARM declared recently?
Past results dates for AARTIPHARM will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
